These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36064856)

  • 1. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
    Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
    J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
    Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
    Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.
    Yao N; Fu S; Wu Y; Tian Z; Feng Y; Li J; Luo X; Yang Y; Ji F; Chen Y; Liu J; Zhao Y; Chen T
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1197-1206. PubMed ID: 36082797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
    Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level-Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study.
    Segeral O; Dim B; Durier C; Prak S; Chhim K; Vong C; Pech S; Tiv S; Nem B; Hout K; Nouhin J; Chhun S; Borand L
    Clin Infect Dis; 2020 Dec; 71(10):e587-e593. PubMed ID: 32188982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
    E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
    BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study.
    Ségéral O; N'Diaye DS; Prak S; Nouhin J; Chhun S; Khamduang W; Chim K; Roque-Afonso AM; Piola P; Borand L; Ngo-Giang-Huong N; Rouet F;
    J Clin Virol; 2018 Dec; 109():29-34. PubMed ID: 30388664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HBV-DNA and HBeAg as antiviral therapeutic indicators among HBV-infected pregnant women: a systematic review and meta-analysis.
    Liu X; Chen C; Jiang D; Cui D; Yan D; Zhou Y; Ding C; Lan L; Huang C; Zhang X; Li L; Zhu C; Yang S
    Ann Palliat Med; 2021 Sep; 10(9):9362-9371. PubMed ID: 34379980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
    World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
    Joshi SS; Gao S; Castillo E; Coffin CS
    Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women.
    Nguyen MN; Nguyen TTH; Pham TDH; Khuu VN; Hoang QC; Nguyen VT; Tran NH
    J Infect Dev Ctries; 2023 Oct; 17(10):1489-1492. PubMed ID: 37956384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.
    Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A;
    J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases.
    Han Z; Zhang Y; Zhou J; Wang Q; Huang Y; Hou H
    BMC Infect Dis; 2021 Jul; 21(1):716. PubMed ID: 34330230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
    Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.